Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia

Center for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States.http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf; 2014 Accessed 20.10.15. Jaiswal, 2014, Lipids and lipid management in diabetes, Best Pract Res Clin Endocrinol Metab, 28, 325, 10.1016/j.beem.2013.12.001 Cardovacular Disease and Diabetes. American Heart Association Website. http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp/#.VqfJL5orKUk. Accessed 2601.16. Wu, 2014, Diabetic dyslipidemia, Metabolism, 63, 1469, 10.1016/j.metabol.2014.08.010 Cholesterol Treatment Trialists’ (CTT) Collaboration, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 Ng, 2013, Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets, Can J Diabetes, 37, 319, 10.1016/j.jcjd.2013.07.062 Chehade, 2013, Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management, Drugs, 73, 327, 10.1007/s40265-013-0023-5 Carmena, 2004, Atherogenic lipoprotein particles in atherosclerosis, Circulation, 109, S1112 Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E Jellinger, 2012, American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis, Endocr Pract, 18, S1, 10.4158/EP.18.S1.1 Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2889, 10.1016/j.jacc.2013.11.002 2013 Prevention Guideline Tools: CV Risk Calculator. American Heart Association Website. http://my.americanheart.org/cvriskcalculator. Accessed 28.10.15. American Diabetes Association, 2015, Standards of medical care in diabetes—2015, Diabetes Care, 38, S1 Ahmad, 2014, Statin intolerance, Am J Cardiol, 113, 1765, 10.1016/j.amjcard.2014.02.033 Sattar, 2014, The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice, Atheroscler Suppl, 15, 1, 10.1016/j.atherosclerosissup.2014.04.001 Chan, 2015, Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?, Curr Atheroscler Rep, 17, 472, 10.1007/s11883-014-0472-7 Mogadam, 2014, Do statins increase the risk of diabetes or is it guilt by association?, Curr Opin Endocrinol Diabetes Obes, 21, 140, 10.1097/MED.0000000000000050 Brault, 2014, Statin treatment and new-onset diabetes: a review of proposed mechanisms, Metabolism, 63, 735, 10.1016/j.metabol.2014.02.014